Evaluation of mastectomy with immediate autologous latissimus dorsi breast reconstruction following neoadjuvant chemotherapy and radiation therapy: A single institution study of 111 cases of invasive breast carcinoma
- PMID: 27134148
- DOI: 10.1016/j.ejso.2016.03.024
Evaluation of mastectomy with immediate autologous latissimus dorsi breast reconstruction following neoadjuvant chemotherapy and radiation therapy: A single institution study of 111 cases of invasive breast carcinoma
Abstract
Purpose: The aim of the study was to evaluate morbidity and patient satisfaction following surgically treated skin-sparing mastectomy (SSM) with immediate breast reconstruction (IBR) following mastectomy with neoadjuvant chemotherapy (NACT), and preoperative radiotherapy (RT), for operable invasive breast cancer.
Patients and methods: This retrospective single-institution study included 111 patients who underwent a mastectomy with IBR after RT and/or NACT for invasive breast carcinoma at the Institut de Cancérologie de l'Ouest Paul Papin from January 1997 to January 2012. Only patients with breast reconstruction by autologous latissimus dorsi flap with (LDI) or without (ALD) implant were considered. The primary endpoints were the delay in therapeutic sequence, post-operative complication rate, surgical revision rate, time of hospitalization and the anonymous analysis of the patient satisfaction survey.
Results: 111 patients underwent mastectomy after RT. The median age was 48 years old and the median body mass index (BMI) was 23.6. SSM were performed in 94.5% of cases. The median interval between the end of chemotherapy (CT) and the beginning of RT was 30 days while the median interval between the end of RT and surgery was 41 days. The rate of primary complications was 66.6% including seroma secretion (reduced to 10.8% when seroma secretion was excluded). The necrosis rate was 5.4%. The average patient satisfaction score for the reconstruction was 17 out of 20. Five-year disease-free and overall survival rates were 93.2% and 98.3% respectively with a median follow-up of 31.6 months. There was only one case of local relapse diagnosed after seven years of follow-up.
Conclusion: This study shows that our therapeutic sequence does not appear to increase IBR morbidity and remains within the acceptable safety margins of oncological treatment. It also gives a high quality aesthetic result that helps to maintain patient self-esteem.
Keywords: Breast cancer; Complications; Immediate breast reconstruction; Latissimus dorsi flap; Local recurrence; Satisfaction; Skin-sparing mastectomy.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
A Prospective Study on Skin-Sparing Mastectomy for Immediate Breast Reconstruction with Latissimus Dorsi Flap After Neoadjuvant Chemotherapy and Radiotherapy in Invasive Breast Carcinoma.Ann Surg Oncol. 2016 Jul;23(7):2350-6. doi: 10.1245/s10434-016-5146-y. Epub 2016 Mar 8. Ann Surg Oncol. 2016. PMID: 26957504
-
Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.Eur J Surg Oncol. 2011 Oct;37(10):864-70. doi: 10.1016/j.ejso.2011.07.009. Epub 2011 Aug 16. Eur J Surg Oncol. 2011. PMID: 21843920
-
New concept for immediate breast reconstruction for invasive cancers: feasibility, oncological safety and esthetic outcome of post-neoadjuvant therapy immediate breast reconstruction versus delayed breast reconstruction: a prospective pilot study.Breast Cancer Res Treat. 2010 Jul;122(2):439-51. doi: 10.1007/s10549-010-0951-7. Epub 2010 May 26. Breast Cancer Res Treat. 2010. PMID: 20502959
-
New treatment sequence protocol to reconstruct locally advanced breast cancer.ANZ J Surg. 2013 Sep;83(9):630-5. doi: 10.1111/ans.12110. Epub 2013 Mar 15. ANZ J Surg. 2013. PMID: 23496238 Review.
-
Breast Reconstruction and Radiation Therapy.Cancer Control. 2018 Jan-Dec;25(1):1073274818795489. doi: 10.1177/1073274818795489. Cancer Control. 2018. PMID: 30132338 Free PMC article. Review.
Cited by
-
Does response to neo-adjuvant chemotherapy impact breast reconstruction?Breast J. 2018 Jul;24(4):567-573. doi: 10.1111/tbj.12977. Epub 2018 Jan 8. Breast J. 2018. PMID: 29316048 Free PMC article.
-
Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial.JAMA Netw Open. 2024 Apr 1;7(4):e245217. doi: 10.1001/jamanetworkopen.2024.5217. JAMA Netw Open. 2024. PMID: 38578640 Free PMC article. Clinical Trial.
-
Multidisciplinary and Tailored Treatment of Locally Advanced Breast Cancer in Progression during Neoadjuvant Chemotherapy: Case Report.Curr Oncol. 2024 May 16;31(5):2856-2866. doi: 10.3390/curroncol31050217. Curr Oncol. 2024. PMID: 38785498 Free PMC article.
-
Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study.Lancet Oncol. 2022 May;23(5):682-690. doi: 10.1016/S1470-2045(22)00145-0. Epub 2022 Apr 7. Lancet Oncol. 2022. PMID: 35397804 Free PMC article.
-
A Retrospective Study of Latissimus Dorsi Flap in Immediate Breast Reconstruction.Front Oncol. 2021 Nov 4;11:598604. doi: 10.3389/fonc.2021.598604. eCollection 2021. Front Oncol. 2021. PMID: 34804907 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical